Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 16
	QLoRA Alpha: 24.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: This study suggests that BF% is a more important marker of undernutrition than birth weight percentiles. Further studies are needed to validate these findings. The authors recommend that BF% be considered as an alternative measure for assessing nutritional status in newborns. Future studies should also examine whether there is an optimal BF% level that best identifies those at risk of undernutrition. This will provide a clinically useful tool for early identification of neonates at risk of malnutrition. It is important to note that this is only one of many potential markers of undernutrition; further investigation is required to determine whether other markers may be equally or more effective.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.7
Reasoning:
The assistant's response accurately captures the study's main conclusion that BF% is more closely associated with neonatal morbidity than birth weight percentiles and appropriately notes the need for further validation. However, it slightly overstates the claim by phrasing BF% as a "more important marker" rather than the more precise "more closely associated," and it omits key study details (effect sizes, prevalence, and the point that BF% can identify appropriately grown but undernourished neonates and exclude small neonates not at risk). A more precise summary would include those specifics and a clearer statement of limitations.

conciseness: 0.6
Reasoning:
The response answers the question directly (states BF% appears to be a better marker) but is somewhat wordy and repetitive—repeatedly calls for further studies and future investigations that are not necessary to a concise answer. It could be shortened to a single clear sentence stating the study's conclusion and the need for validation.



relevance: 0.6
Reasoning:
The assistant's reply is relevant to the question and correctly conveys the study's main implication — that neonatal BF% is a better marker of undernutrition than birth weight percentiles. However, it does not cite or quote any specific text or numeric results from the provided context (for example the ORs, prevalence, or the phrase that BF% is "more closely associated" with neonatal morbidity). It also adds an unsupported statement that "the authors recommend" BF% as an alternative measure, which is not explicitly shown in the context. The caution about needing further studies is appropriate.

coherence: 0.8
Reasoning:
The response is generally coherent and well-structured: it answers the question directly (BF% appears to be a better marker), summarizes the study's implication, and appropriately adds caveats about needing further validation and considering other markers. Weaknesses for coherence: it slightly overstates ("more important marker" rather than "more closely associated"), and it is generic—no mention of the study's quantitative findings (e.g., ORs, prevalence) that would strengthen the conclusion. Overall the response communicates the main point clearly and includes sensible caution.

helpfulness: 0.6
Reasoning:
The assistant's response correctly conveys the study's overall conclusion that BF% appears to be a better marker of neonatal undernutrition than birth weight percentiles and appropriately cautions that further validation is needed. However, it is vague and misses several important, actionable details from the study: it does not report the comparative effect sizes or odds ratios (BF% OR 1.30 vs birth weight percentile OR 1.03), the prevalence numbers (low BF% identified 73 per 1,000; neonatal morbidity 3.4%), nor the key nuance that BF% can detect undernourished infants who are appropriately grown by weight and can exclude small infants who are not at risk. Including those data and brief notes on study limits (term infants only, measurement by air displacement plethysmography, sample size) would make the answer substantially more informative.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The results of this study suggest that it is possible to obtain good limb salvage rates in ischemic Charcot neuroarthropathy. However, the choice of treatment may depend on the severity of the condition and its association with critical limb ischemia. In this case series, we observed a high limb salvage rate without major amputations. This result suggests that it is possible to perform endovascular revascularization, surgical debridement and orthopedic correction in cases with severe ischemic Charcot neuroarthropathy. It is important to remember that Charcot neuroarthropathy represents a spectrum of diseases with different causes, clinical features and prognosis. The decision to treat with endovascular or surgical methods should be made according to the severity and extent of the disease. Endovascular revascularization can be performed as an alternative to surgery in some cases, particularly those presenting with acute ischemic symptoms. However, the indication to use these techniques has to be carefully evaluated before starting any treatment. Therefore, we recommend performing an individualized evaluation of each patient in order to choose the most appropriate treatment option. Further studies are needed to confirm these results and to investigate whether the timing of treatment influences the outcome.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.8
Reasoning:
The assistant's reply is generally accurate and aligned with the study findings: it notes that combined endovascular revascularization plus surgical/orthopedic treatment can achieve high limb salvage in ischemic Charcot neuroarthropathy and appropriately emphasizes individualized treatment based on severity. However, it is somewhat imprecise: it avoids stating that revascularization is often necessary to enable and support surgical/orthopedic limb-salvage procedures (the ground-truth point), and it phrases endovascular revascularization as an "alternative to surgery" in a way that could confuse revascularization (vascular intervention) with orthopedic surgery. Overall the answer is cautious and mostly correct but slightly vague on the necessity and roles of revascularization.

conciseness: 0.5
Reasoning:
The response addresses the question but is wordy and somewhat repetitive. It reiterates study findings and hedges rather than giving a direct, concise answer (e.g., that ischemic Charcot often requires revascularization to enable surgical/orthopedic treatment and improve limb salvage). The key point could have been stated much more succinctly.

relevance: 0.7
Reasoning:
The assistant's reply is generally relevant: it answers the question by stating that ischemic Charcot is a spectrum that may require different, individualized treatments and it refers to the study's outcome (good limb salvage with combined endovascular, surgical and orthopedic treatment). However it does not cite the study's specific data (e.g., 90% limb salvage, mean healing time ~197 days) and includes a mildly imprecise/unsupported phrase (presenting endovascular revascularization as an "alternative to surgery" for acute ischemic symptoms), so it is somewhat broad and partly speculative.

coherence: 0.6
Reasoning:
The answer is generally coherent and organized: it summarizes the study's implication that limb salvage is achievable with combined endovascular, surgical and orthopedic care and emphasizes individualized decision-making. However, it is somewhat noncommittal and repetitive, and it fails to state clearly that ischemic Charcot foot is a distinct clinical situation that commonly requires revascularization to enable limb- and foot-salvage (as indicated by the ground truth and study results); it also omits the study's numeric outcomes that would strengthen the conclusion.

helpfulness: 0.6
Reasoning:
The assistant's reply is partially helpful: it correctly notes that ischemic Charcot neuroarthropathy is a spectrum disorder and that treatment should be individualized, and it appropriately mentions combining revascularization with surgical/orthopedic care to improve limb salvage. However the answer is vague, noncommittal about the necessity of revascularization in ischemic cases (the ground-truth study supports revascularization to enable limb/foot salvage), and includes an imprecise statement that endovascular revascularization can be an "alternative to surgery in some cases" without clarifying the distinction between revascularization approaches and when each is indicated. It also omits specific study outcomes (limb-salvage rate, healing time) that would have strengthened the response.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Radical hysterectomy for endometrial cancer patients with suspected cervical involvement did not improve overall survival or reduce recurrence rate compared to other surgical procedures. Further studies should be performed to determine whether this operation is necessary in these cases. It may be considered when there are unfavorable features on histopathological examination such as high grade, lymphatic invasion, or positive lymph nodes. In addition, the RH should be performed by experienced surgeons and with adequate perioperative care to minimize complications. However, it should be noted that RH is a major operation and requires careful evaluation before making decisions. Adequate discussion regarding risks and benefits of surgery should be carried out with the patient. Furthermore, the role of RH in advanced stages of endometrial cancer remains unclear. Thus, prospective randomized trials comparing RH with other surgical procedures are warranted.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.6
Reasoning:
The assistant correctly summarized the main findings: radical hysterectomy (RH) did not improve overall survival or recurrence outcomes and further prospective trials are warranted. However, the reply goes beyond the presented study in recommending that RH “may be considered” for unfavorable features (high grade, lymphatic invasion, positive nodes) — the GOTIC-005 analysis did not identify type of hysterectomy as an independent prognostic factor and did not provide evidence that RH benefits subgroups with those features. The response also omits the study’s clear point that perioperative and late adverse events were more frequent with RH (longer operative time, more transfusions, higher rates of urinary dysfunction), instead giving only generic cautions about complications. Overall the answer is mostly accurate about the primary conclusion but includes an unsupported clinical recommendation and misses some adverse-event details.

conciseness: 0.7
Reasoning:
The response states the main finding clearly (radical hysterectomy did not improve survival or recurrence) but includes several additional recommendations and caveats (when RH may be considered, surgeon experience, perioperative care, unclear role in advanced stages) that are not necessary to answer the study question and reduce overall conciseness. Overall, reasonably concise but somewhat wordy.

relevance: 0.8
Reasoning:
The assistant's reply correctly states the study's main conclusion that radical hysterectomy (RH) did not improve overall survival or reduce recurrence and that further prospective studies are needed. It also appropriately notes increased perioperative risk of RH in general terms. However, it adds recommendations (e.g., consider RH for high-grade/lymphatic invasion, comments about advanced-stage disease, and surgeon experience) that are not directly supported by the provided study text and omits some specific findings (e.g., which factors were identified as independent prognostic factors). Overall the answer is relevant to the question but includes minor unsupported inferences.

coherence: 0.7
Reasoning:
The assistant's reply is overall coherent and well-structured: it correctly states the main finding that radical hysterectomy (RH) did not improve survival or recurrence outcomes, calls for further prospective studies, and notes increased procedural risks. However, it adds speculative clinical recommendations (e.g., considering RH for high-grade disease, lymphatic invasion, or positive nodes) that are not supported by the presented GOTIC-005 data, and it could more directly emphasize the study's finding of higher perioperative and late adverse events with RH. 

helpfulness: 0.7
Reasoning:
The assistant's reply is generally helpful and concise: it correctly states the main finding that radical hysterectomy (RH) did not improve overall survival or reduce recurrence compared with less extensive procedures, notes the higher complication burden with RH, and appropriately calls for prospective studies. These points align with the GOTIC-005 study summary.

Weaknesses: the answer goes beyond the study by suggesting RH "may be considered" for unfavorable features (high grade, lymphatic invasion, positive nodes) — that recommendation is not supported by the presented retrospective analysis, which did not identify hysterectomy type as an independent prognostic factor. That suggestion could be misleading without evidence. The rest of the recommendations (use experienced surgeons, careful risk–benefit discussion, need for trials) are reasonable and consistent with the ground truth.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD are an important issue and should be addressed by optimizing perioperative care. Prospective studies are needed to identify risk factors for readmissions, which would help us develop strategies to reduce readmission rates. In addition, prospective studies could also focus on evaluating the efficacy of interventions aimed at reducing readmissions. Although some risk factors cannot be modified, others may be modifiable through changes in perioperative care. The most critical risk factor associated with readmissions after PD is pancreatic fistula. However, other risk factors such as prolonged LOS and multivisceral resection are potentially modifiable. To prevent readmissions, we need to focus on improving patient outcomes by providing better preoperative care and optimizing perioperative management. This includes reducing LOS, minimizing blood transfusion, and using pain management protocols. Future studies should also evaluate the cost-effectiveness of these interventions. Our experience suggests that many readmissions can be avoided if we focus on optimizing patient care. We propose a prospective, randomized trial to determine whether postoperative care can be optimized to reduce readmissions.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.6
Reasoning:
The assistant's reply is partially correct but incomplete and somewhat speculative. It correctly identifies pancreatic fistula and multivisceral/complex resection (complexity of the initial resection) as important risk factors for readmission after PD. However, it fails to emphasize the ground-truth point that roughly half of readmissions occur very early (≤7 days) and that efforts should be directed specifically at preventing these early readmissions. The answer is also generic in calling for prospective trials despite retrospective data already identifying independent predictors, and it suggests interventions (minimizing blood transfusion, reducing LOS) that were not supported by the presented study and could be misleading without evidence. Overall useful but misses the key emphasis on early readmissions and includes unsupported recommendations.

conciseness: 0.3
Reasoning:
The response is relevant but overly wordy and somewhat repetitive. It identifies pancreatic fistula and complex resections as contributors to readmission but fails to state the key finding that half of readmissions occur within 7 days and that preventing early readmissions should be a priority; it also makes broad recommendations and calls for trials rather than succinctly summarizing the actionable findings. Overall it is not concise or tightly focused on the study’s main takeaways.

relevance: 0.6
Reasoning:
The response is partially relevant: it correctly identifies pancreatic fistula and multivisceral resection (complexity of resection) and prolonged length of stay as factors associated with readmission — all drawn from the provided context. However, it fails to emphasize that half of readmissions are early (≤7 days) and that preventing early readmissions was highlighted in the ground truth. It also proposes some interventions (e.g., minimizing blood transfusion, specific pain protocols) that are not mentioned or supported by the provided text. Overall the answer addresses the question but omits a key finding and adds unsupported recommendations.

coherence: 0.6
Reasoning:
The response is generally coherent and organized: it identifies pancreatic fistula as a key risk factor, notes that some risks may be modifiable, and proposes prospective trials and perioperative optimization to reduce readmissions. However it is fairly generic, repetitious, and does not closely reflect or prioritize several specific findings from the study (notably that half of readmissions occur within 7 days and that complexity of resection/multivisceral resection and ICU admission were independent predictors). It also suggests some measures (e.g., minimizing transfusion) that are not supported by the presented data, and it misses concrete, evidence-aligned prevention strategies (for example targeting early postdischarge problems such as ileus, DGE, and pneumonia). Overall the answer is coherent but incomplete and not tightly grounded in the study results.

helpfulness: 0.6
Reasoning:
The assistant correctly identifies pancreatic fistula and complexity of resection (multivisceral resection) as important predictors and appropriately calls for prospective study. However the reply is vague and misses a key, evidence-based point from the ground truth: half of readmissions occur within 7 days and prevention efforts should particularly target early readmissions (and their common causes such as ileus, delayed gastric emptying, and pneumonia). The answer also suggests interventions (eg, reducing LOS, minimizing transfusion) without linking them to the reported predictors or acknowledging that prolonged LOS may be a marker of complications rather than a causal, easily modifiable factor. Practical, targeted prevention measures (early postdischarge follow-up, specific measures to reduce pancreatic fistula, discharge planning) are not offered.

================================================================================
Average correctness Score: 0.49
Average conciseness Score: 0.465
Average relevance Score: 0.525
Average coherence Score: 0.57
Average helpfulness Score: 0.515
